Yan Leyfman, MD (@yleyfman) 's Twitter Profile
Yan Leyfman, MD

@yleyfman

Dir @MedNewsWeek | Med Correspondent @onclive | Research #Oncology #COVID19 #Immunotherapy #celltherapy #tcellrx #CART #bmtsm | About Me: nyti.ms/2VG3gUK

ID: 1247994699425726467

linkhttp://bit.ly/2NTCqEz calendar_today08-04-2020 21:08:25

21,21K Tweet

2,2K Followers

2,2K Following

Yan Leyfman, MD (@yleyfman) 's Twitter Profile Photo

We are excited to be Shining the Spotlight on the work of Global Leader & Keynote Speaker, Dr. Jasmine Zain of City of Hope as she discusses the challenges in CAR T cell therapies in T Cell Lymphomas on MedNewsWeek Medical Spotlight in partnership with OncLive.com.

Vallabhaneni Sree Harshitha (@harshithavalla) 's Twitter Profile Photo

Missed it? Donโ€™t worry! ๐Ÿ™Œ You can still watch Dr. Marco Davilaโ€™s inspiring talk on โ€œGene and Cell Therapy: Shaping the Future of Medicineโ€ right here! ๐ŸŽฅ๐Ÿ‘‡ ๐ŸŽž Watch it here: onclive.com/mednews/gene-aโ€ฆ

Missed it? Donโ€™t worry! ๐Ÿ™Œ You can still watch Dr. Marco Davilaโ€™s inspiring talk on โ€œGene and Cell Therapy: Shaping the Future of Medicineโ€ right here! ๐ŸŽฅ๐Ÿ‘‡  

๐ŸŽž Watch it here: onclive.com/mednews/gene-aโ€ฆ
Kennedyeureka1 (@kennedyeureka1) 's Twitter Profile Photo

Don't miss out! If you didn't get a chance to see Dr. Marco Davila's poster presentation on 'Gene and Cell Therapy: Shaping the Future of Medicine', you can still access it by clicking the link below." onclive.com/view/gene-and-โ€ฆ

Shreevikaa Kannan (@shreevikaa2029) 's Twitter Profile Photo

๐Ÿ“ฃ Don't miss the opportunity to hear from Dr. Jasmine Zain as she delves into the challenges of CAR-T therapies in T-cell lymphoma. ๐Ÿ“ฃ Registration link:- ow.ly/Lpg750T4Z9L

๐Ÿ“ฃ Don't miss the opportunity to hear from Dr. Jasmine Zain as she delves into the challenges of CAR-T therapies in T-cell lymphoma. ๐Ÿ“ฃ 

Registration link:- ow.ly/Lpg750T4Z9L
Harshal Chorya (@harshalchorya11) 's Twitter Profile Photo

๐Ÿšจ Donโ€™t Miss This #MedicalSpotlight! ๐Ÿšจ Step into the future of cancer treatment with ๐ŸฉบDr. Jasmine Zain, MD, a trailblazer in T-cell lymphoma research. Sheโ€™ll be unpacking the "Challenges in CAR-T therapies in T cell lymphomas" a topic that's reshaping #Hematology and #Oncology

๐Ÿšจ Donโ€™t Miss This #MedicalSpotlight! ๐Ÿšจ
Step into the future of cancer treatment with ๐ŸฉบDr. Jasmine Zain, MD, a trailblazer in T-cell lymphoma research. Sheโ€™ll be unpacking the "Challenges in CAR-T therapies in T cell lymphomas" a topic that's reshaping #Hematology and #Oncology
Jenna (@jenna_ghazal_) 's Twitter Profile Photo

September 7th, 4 pm ESTโ€ผ๏ธ Want to learn about the challenges in CAR-T therapies in T-cell lymphomas! MedNewsWeek is hosting the wonderful Dr. Zain as she enlightened us on car-t therapies! ๐Ÿฉบโš•๏ธ Don't forget to register for the event with this link: ow.ly/Lpg750T4Z9L

September 7th, 4 pm ESTโ€ผ๏ธ

Want to learn about the challenges in CAR-T therapies in T-cell lymphomas! <a href="/MedNewsWeek/">MedNewsWeek</a> is hosting the wonderful Dr. Zain as she enlightened us on car-t therapies! ๐Ÿฉบโš•๏ธ

Don't forget to register for the event with this link: ow.ly/Lpg750T4Z9L
Yan Leyfman, MD (@yleyfman) 's Twitter Profile Photo

Had an incredible time attending my first SOHO meeting & presenting our research! Appreciate the enriching experience & the chance to connect with some of the brightest stars in oncology ๐ŸŒŸ. Success is built on great mentorshipโ€” thank you, Dr. Park for always believing in me!

Had an incredible time attending my first SOHO meeting &amp; presenting our research! Appreciate the enriching experience &amp; the chance to connect with some of the brightest stars in oncology ๐ŸŒŸ. Success is built on great mentorshipโ€” thank you, Dr. Park for always believing in me!
Yan Leyfman, MD (@yleyfman) 's Twitter Profile Photo

Study found U-shaped association between BRI and all-cause mortality.ย Findings propose BRI as a noninvasive screening tool for mortality risk estimation. jamanetwork.com/journals/jamanโ€ฆ #obesity #pandemic #lifestyle #medicine